Home » Cyclacel Pharmaceuticals Reaches Agreement With FDA
Cyclacel Pharmaceuticals Reaches Agreement With FDA
Cyclacel Pharmaceuticals, Inc. … Monday announced that it has reached agreement with the U.S. Food and Drug Administration regarding a Special Protocol Assessment on the design of a pivotal Phase 3 trial for the Company’s sapacitabine oral capsules as a front-line treatment in elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia who are not candidates for intensive induction chemotherapy.
MSN
MSN
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May